The benefit of atrial septal defect closure in elderly patients by Komar, Monika et al.
© 2014 Komar et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0)  
License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further 
permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on 
how to request permission may be found at: http://www.dovepress.com/permissions.php
Clinical Interventions in Aging 2014:9 1101–1107
Clinical Interventions in Aging Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
1101
O r I g I n A l  r e s e A r C h
open access to scientific and medical research
Open Access Full Text Article
http://dx.doi.org/10.2147/CIA.S62313
Monika Komar
Tadeusz Przewlocki
Maria Olszowska
Bartosz sobien
Piotr Podolec
Department of Cardiac and Vascular 
Diseases, Institute of Cardiology, 
Jagiellonian University, Krakow, Poland
Correspondence: Monika Komar
Department of Cardiac and Vascular 
Diseases, Institute of Cardiology, 
Jagiellonian University, John Paul II 
hospital, 80 Pradnicka street, Kraków, 
lesser Poland 31-202, Poland
Tel +48 12 614 2287
Fax +48 12 423 4376
email moni_s@interia.pl
The benefit of atrial septal defect closure  
in elderly patients*
Objective: Closure of an atrial septal defect in elderly patients is controversial. The aim of the 
study was to evaluate the outcomes of transcatheter closure of secundum atrial septal defects 
(ASDs) in elderly patients.
Patients and methods: From a total of 488 patients with ASDs who underwent transcatheter 
closure, 75 patients aged over 60 years (45 female, 30 male) with a mean age of 65.3±15.7 
(60–75) years were analyzed. All patients had an isolated secundum ASD with a mean pulmo-
nary blood flow:systemic blood flow of 2.84±1.9 (1.5–3.9). Symptom-limited treadmill exercise 
tests with respiratory gas-exchange analysis and transthoracic color Doppler echocardiographic 
study, as well as quality of life measured using the Short Form (36) Health Survey (SF-36) were 
repeated in all patients before the procedure and after 12 months of follow-up.
Results: The atrial septal device was successfully implanted in all patients (procedure time 
37.7±4.5 [13–59] minutes, fluoroscopy time 11.2±9.9 [6–40] minutes). There were no major 
complications. The defect echo diameter was 17.7±15.8 (12–30) mm. The mean balloon-stretched 
diameter of ASDs was 22.4±7.9 (14–34) mm. The diameter of the implanted devices ranged from 
16 to 34 mm. Significant improvement of exercise capacity was noted at 6 and 12 months after 
the procedure. Exercise time within 6 months of ASD closure was longer (P0.001) compared 
to baseline values, and also oxygen consumption increased (P0.001). Seven quality-of-life 
parameters (except mental health) improved at 12-month follow-up compared to baseline data. 
The mean SF-36 scale increased significantly in 66 (88%) patients, with a mean of 46.2±19.1 
(5–69). As early as 1 month after the procedure, a significant decrease of the right ventricular 
dimension and the right atrium dimension was observed (P0.001). The right ventricular 
dimension decreased in 67 patients (89.3%).
Conclusion: Closure of ASDs in elderly patients caused significant clinical and hemodynamic 
improvement after percutaneous treatment, which was maintained during long-term follow-up, 
justifying this procedure in old age.
Keywords: atrial septal defect, transcatheter closure, elderly, cardiopulmonary exercise test, 
quality of life
Introduction
Atrial septal defects (ASDs) may not uncommonly remain undiagnosed until adulthood. 
The most common presenting symptoms at adult age are palpitations and exercise 
intolerance manifested as either exertional dyspnea or fatigue, which increase with 
age.1–3 More serious complications are typically seen in older patients with previously 
unrecognized ASDs who have been exposed to large left-to-right shunting for a long 
period.4,5 Closure of an ASD in patients with a hemodynamically significant shunt 
has become the standard of care in recent years. Correction of ASDs prevents the 
*Parts of this paper were published as abstracts during the European Society of Cardiology Congress in 
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 development of pulmonary hypertension, cardiac  arrhythmia, 
and heart failure.1–4 The indications for ASD closure in adults, 
however, are ambiguous. The most controversial issue is 
selection of candidates for ASD closure who have normal 
pulmonary artery pressure, absent or negligible clinical 
symptoms, and are over 40–60 years of age.5–9 The closure 
of ASDs in elderly patients remains controversial. The aim 
of this study was to evaluate the outcomes of transcatheter 
closure of secundum ASDs in elderly patients.
Patients and methods
Patient population
Of a total of 488 consecutive patients with ASDs who under-
went transcatheter closure over a period of 10 years in our 
department, 75 patients (45 female, 30 male) over 60 years 
of age with a mean age of 65.3±15.7 (60–75) years were 
analyzed. All patients had an isolated secundum ASD with 
a mean left-to-right shunt (ratio of pulmonary to systemic 
blood flow [Qp:Qs] 2.84±1.9 (1.5–3.9) in echo examination. 
All those patients had the coexisting impairment of physi-
cal status, enlargement of right-heart cavity, or pulmonary 
hypertension. The major demographic characteristics of 
patients are summarized in Table 1.
Protocol
A detailed description of the transcatheter closure technique 
has been given previously.4,5 The procedure was performed 
under local anesthesia. A complete hemodynamic evalua-
tion was performed, as well as right-heart catheterization 
(measured pulmonary artery pressure and Qp:Qs shunt) and 
pulmonary arteriography to exclude anomalous pulmonary 
venous drainage, and coronary angiography. All procedures 
were performed with continuous transesophageal echocardio-
graphic monitoring. The ASD was sized with a sizing balloon 
catheter; the stretched diameter of the ASD was defined as 
the diameter of a balloon that could be withdrawn across the 
defect with mild resistance and slight deformity. The selected 
device was either the same size as the stretched diameter 
or 1 mm larger. When the device was deployed across the 
defect, its position as well as stability were assessed by fluo-
roscopy and transesophageal echocardiography. Complete 
ASD closure was defined as no residual shunt; a color Dop-
pler signal width of less than 1 mm was considered trivial 
shunting. After the procedure, the patients were treated with 
75 mg acetylsalicylic acid and 75 mg clopidogrel once 
daily for 1 month and then 325 mg acetylsalicylic acid for 
11 months to provide antithrombotic protection until full 
device endothelialization.
The assessment was made in compliance with the fol-
lowing constraints:
•	 clinical study – within 7 days before the procedure and 
then at 1, 6, and 12 months after
•	 transthoracic echocardiographic examination – within 
7 days before the procedure and then at 1, 6, and 12 
months after
•	 cardiopulmonary exercise test – within 7 days before the 
procedure and then at 6 and 12 months after
•	 quality-of-life measurement – within 7 days before the 
procedure and then at 12 months after.
Clinical study
The clinical study was based on subjective opinions of the 
patients concerning their functional capacity. We assessed 
the frequency of dyspnea incidences and palpitations.
Transthoracic echocardiographic 
examination
Transthoracic echocardiographic examination was performed 
using a Toshiba Power Vision (Toshiba, Otawara, Japan) 
machine with a 5.0 MHz multiplane probe, according to a 
standard protocol including color flow Doppler data. After a 
comprehensive echocardiographic study of right ventricular 
and right atrial major and minor dimensions, left ventricu-
lar dimensions were measured in end-diastole. M-mode 
echocardiography from the parasternal long-axis view was 
used to measure right ventricular dimensions. The apical 
four-chamber view was used to measure the right atrial and 
the right ventricle size. The major axis of right atrium was 
measured from the tricuspid annulus to the atrial superior 
wall, and the minor axis was measured perpendicularly 
to the major axis at half of the length of the latter. Each 
measurement was averaged from five consecutive cardiac 
cycles. Two independent cardiologists trained in echocar-
diography agreed on the measurements. Follow-up included 
Table 1 Demographic characteristics of patients
Patients (n=75)
smoking 15 (20%)
Obesity 18 (24%)
Diabetes mellitus 4 (5.3%)
hypertension 29 (38.6%)
Dyslipidemia 31 (41.3%)
Coronary artery disease 10 (13.3%)
Pulmonary hypertension* 12 (16%)
Atrial fibryillation 21 (28%)
Note: *Measured on right-heart catheterization – mean pulmonary artery pressure 
over 25 mmhg.
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a  complete echocardiographic study with a precise location 
and measurement of any residual shunt as well as position-
ing of the device.
Cardiopulmonary exercise test
In order to objectively assess the clinical and functional status 
of the patients in all the cases, we performed cardiopulmonary 
exercise tests. Maximal cardiopulmonary testing was per-
formed on an ergometer cycle. Peak oxygen uptake, carbon 
dioxide production, and minute ventilation were measured 
with a computerized breath-by-breath analyzer (Vmax 29™; 
CareFusion, San Diego, CA, USA). Patients performed a 
maximal exercise test using a 1-minute incremental bicycle 
protocol with a work-rate increment of 10 W/minute. Criteria 
for test ending were considered patient exhaustion or a respi-
ratory exchange ratio 1.09. A 12-lead electrocardiogram 
was also monitored throughout the study, and cuff blood 
pressure was determined manually every 2 minutes. Standard 
equations were used to generate predicted values for baseline 
spirometric and peak exercise parameters.
Quality of life
This objective study was completed with the subjective 
opinions of the patients concerning their clinical status. 
In each case, we assessed quality of life using the Short 
Form (36) Health Survey (SF-36). Patients completed 
the SF-36, the best-known questionnaire in measuring 
health status. The number “36” refers to 36 questions 
that concern eight aspects of general health and quality 
of life, ie, physical function, role – physical, bodily pain, 
general health, vitality, social function, role – emotional, 
and mental health.
statistical analysis
Continuous data are expressed as means ± standard deviation, 
and baseline and follow-up were compared with the paired 
Student t-test. For the comparison of categorical variables, 
the χ2 test was used. The level of statistical significance 
was two-sided and set at P0.05. Multivariate analyses, 
such as multiple forward stepwise regression and canonical 
correlation, were used to evaluate the parameters affect-
ing improvement of quality of life. Statistical analysis was 
performed with SPSS version 15.0.0 for Windows (SPSS, 
Chicago, IL, USA).
Results
The devices were successfully implanted in all the subjects, 
with mean procedure time of 37.7±4.5 (13–59) minutes 
and mean fluoroscopy time of 11.2±9.9 (6–40) minutes. 
The defect echo diameter was 17.7±15.8 (12–30) mm. The 
mean balloon-stretched diameter of ASD was 22.4±7.9 
(14–34) mm. The diameter of the implanted devices ranged 
from 16 to 34 mm. The Amplatzer™ (St Jude Medical, 
St Paul, MN, USA) ASD-closure device was used in 
45 (60%) patients, the StarFlex device (NMT Medical Inc, 
Boston, MA, USA) in five (6.7%) patients, and the Cardia 
(Eagan, MN, USA) ASD device in ten (13.3%) patients. 
There were ten (13.3%) patients with significant coronary 
problems. Six patients underwent medical therapy, and four 
patients underwent percutaneous coronary artery interven-
tion using a stent before the transcatheter closure of ASD. 
There were no serious complications, no deaths, no device 
embolizations, and no fractures of the device. Minor com-
plications were recorded in ten (13.3%) patients with minor 
venous access bleeding without transfusion. All the patients 
remained well with no complications or new symptoms 
at their 12-month follow-up. No patient had any heart-
related hospital admissions. All the patients had a complete 
12-month follow-up.
A significant increase in the number of supraventricular 
(SVE) premature beats/24 hours was noted within 1 month 
after the procedure. There was a reduction of the number of 
supraventricular arrhythmias within the follow-up period, 
so after 12 months of ASD II closure, there were no significant 
differences from baseline data (223±232 versus 211±230).
Clinical study
Transcatheter closure of secundum ASD created improvement 
in the clinical status of the patients in the early follow-up. 
It caused reduction of breathlessness and palpitation as early 
as a month after the procedure (Figures 1 and 2).
Figure 1 Frequency of dyspnea before and after AsD closure.
Abbreviations: ASD, atrial septal defect; NS, not significant.
P<0.001 NS
Before ASD
closure
1 month 12 months6 months
NS
0
75
150
225
300
375
450
Number of patients
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e
Number of patients with dyspnea
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Transthoracic echocardiographic 
examination
Directly after the procedure, transthoracic echocardiog-
raphy showed the residual trivial shunt in seven (9.3%) 
subjects, which disappeared in all cases within the 6-month 
follow-up period. As early as 1 month after the procedure, 
a significant decrease of the right ventricular dimension 
and the right atrium dimension was observed. All the 
analyzed dimensions of the right heart decreased in 67 
patients (89.3%) (Table 2). The residual patients did not 
experience changes.
Cardiopulmonary exercise tests
Significant improvement of exercise capacity was noted 
at 6 and 12 months after the procedure. Exercise time 
within 6 months of ASD closure was longer compared to 
baseline values, and also oxygen consumption increased 
(Table 3).
Quality of life
Apart from the objective improvement of physical activity in 
the cardiopulmonary exercise test, the significant improve-
ment in quality of life in patients based on the SF-36 was also 
noted. Moreover, an advancement of each aspect of quality 
of life was observed, with the exception of mental health. 
The mean SF-36 score increased significantly in 66 (88%) 
patients (46.2±19.1 [5–69]). Total SF-36 scores improved 
from 20.8 to 61.4 points (Table 4).
The canonical correlation analysis showed that the fol-
lowing parameters had an influence on improvement of 
total SF-36 score: improvement in cardiopulmonary test 
(prolonged time of exercise, improvement of maximal 
oxygen consumption [mL/kg/min]) and reduction in the 
right heart (right ventricular area [cm2], right arterial area 
[cm2]); P0.05.
The multiple forward stepwise regression analysis 
revealed that all parameters of the echocardiography study 
and cardiopulmonary exercise test (improvement of maximal 
oxygen consumption [mL/kg/min], F
7,21
=9.2281, P 0.001, 
standard error 2.220) had a strong influence on improvement 
of total SF-36 score.
Discussion
Isolated ASDs constitute the second-most common (after 
bicuspid aortic valve) congenital heart lesion in adults.1,2 
Surgical closure of ASDs has been practiced for about 
45 years.3,4 Since the first attempt in 1976, transcatheter 
closure of secundum ASDs has evolved over the past three 
decades.5–8 Surgical repair of ASDs in patients 60 years 
of age may result in significant mortality and morbidity. 
Harjula et al reported an operative mortality rate of 6% and 
a postoperative morbidity rate of 24% in the form of major 
complications.7 The hospital stay after surgical repair of 
Figure 2 Frequency of palpitations before and after AsD closure.
Abbreviations: ASD, atrial septal defect; NS, not significant.
Before ASD closure 1 month 6 months 12 months
NS
P<0.001 NS
Number of patients
Ti
m
e
0
75
150
225
300
375
450
Number of patients with palpitations
Table 2 echocardiographic parameters before and after AsD closure
Parameter Before ASD 
closure
1 month after 
ASD closure
6 months after 
ASD closure
12 months after 
ASD closure
P-value before 
versus l month
P-value before 
versus 6 months
P-value before 
versus 12 months
rV diastole (mm) 35.5 26.8 24.3 24.4 0.001 0.001 0.001
rV systole (mm) 28.5 24.5 24.4 23.1 0.001 0.001 0.001
rV long axis (mm) 60 55.9 55.3 54.3 0.001 0.001 0.001
rV short axis (mm) 39.6 34.2 32 31.9 0.001 0.001 0.001
rV area (cm2) 19.5 17.3 15.9 12.0 0.001 0.001 0.001
rA long axis (mm) 44.4 39.4 39.9 39.0 0.001 0.001 0.001
rA short axis (mm) 42.3 33.8 34.2 33.7 0.001 0.001 0.001
rA area (cm2) 24.8 20.6 19.3 17.2 0.001 0.001 0.001
lV diastole (mm) 49.9 47.3 45.9 46.2 ns ns ns
lV systole (mm) 35.4 38.5 36.1 38.1 ns ns ns
eF (%) 60.4 59.4 60.1 59.5 ns ns ns
Abbreviations: ASD, atrial septal defect; RV, right ventricle; RA, right atrium; LV, left ventricle; EF, ejection fraction; NS, not significant.
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ASDs in patients 60 years of age ranged from 8 to 20 days 
(average 11 days).7 On the other hand, transcatheter closure 
of ASD has a low morbidity rate and shorter hospital stays 
compared to postoperative surgical complications. Morbidity 
is related to the possible risks of blood transfusions required 
for surgery, which were not required in our patients undergo-
ing percutaneous ASD closure. However, there have been no 
reports comparing results, closure rates, morbidity rates, and 
complications of transcatheter and surgical closure of ASDs 
at the same institution among patients 60 years of age.
The benefits of transcatheter treatment of congenital 
heart diseases are obvious. First of all, we can avoid the 
complications of open heart surgery, especially general 
anesthesia, which is absolutely crucial in elderly patients. 
Another benefit is avoidance of a surgical scar (commonly 
called “scar of the human soul” by psychologists) and shorter 
hospitalization time.8,9
Moreover, the closure of ASDs in elderly patients is 
controversial. Some authors undermine the necessity to 
correct atrial communications in these cases, based on the 
argument that the risk involved in the procedure is greater 
than its benefit.9
Based on some analyses, it would be appear that ASDs 
should be closed when they are identified, irrespective 
of the patient’s age.7–11 However, few data are available 
about the results of this procedure in the elderly popula-
tion (60 years of age) with prolonged shunts. An ASD 
is a congenital heart defect, so if it is diagnosed after 
the age of 60 years, it is always a question whether the 
closure is advisable if symptoms are not severe. What is 
more, symptoms in elderly patients with ASDs are quite 
common, and can be masked because of the numerous 
associated diseases.
Transcatheter closure of ASDs is a safe and effective 
treatment. Over the past few years, an increasing number 
of elderly patients (age 60 years) have been admitted for 
transcatheter closure to prevent ongoing congestive heart 
failure from volume overload.9
Table 3 Parameters of cardiopulmonary exercise test before and after AsD closure
Parameter Before ASD  
closure
6 months after  
ASD closure
12 months after  
ASD closure
P-value before 
versus 12 months
Time of exercise (seconds) 546±71 680±155 834±265 0.001
heart rate (beats/min) 149±28.9 131.2±30.8 121.4±38.2 0.01
heart rate% 90.5±10.2 85.3±12.1 84.9±15.2 0.001
VO2 peak (ml/kg/min) 8.2±3.5 10.1±8 13.5±9.7 0.001
VCO2 (l/min) 1.64±1.1 1.71±0.9 1.78±0.9 0.001
Plus-O2 9.5±1.1 12.1±2.1 12.9±2.5 0.001
VD/VT 0.20±0.19 0.17±0.1 0.17±0.06 0.01
Ve/VCO2 30.1±3.1 24.9±4.1 25.7±3.7 0.05
TAT (seconds) 376±70.7 426±130 499±105 0.001
VO2 AT (ml/kg/min) 13.1±10.01 15.3±10.8 16.8±12.1 0.001
VO2 AT% 37.2±9.4 42.7±10.6 42.9±10.2 0.001
Abbreviations: AsD, atrial septal defect; VO2 peak, peak oxygen consumption; VO2 AT, ventilatory anaerobic threshold; VCO2, production of carbon dioxide; Plus-O2, 
oxygen pulse; VD/VT, tidal volume; Ve/VCO2, ventilatory equivalent for CO2; TAT, time to attain anaerobic treasure; VO2 AT, oxygen consumption in at anaerobic threshold; 
min, minutes.
Table 4 results of the sF-36 before and after AsD closure
Parameter Before ASD closure 12 months after P-value
sF-36 total scale 20.8±31 61.4±31 P0.001
PF-physical function 8.2±1.1 10.2±4.2 P0.01
rP-role physical 6.1±2.7 10.1±1.1 P0.01
BP-bodily pain 7.0±4.0 14.2±4.0 P0.01
gh-general health 4.2±4.9 11.9±4.0 P0.001
V-vitality 7.2±3.3 11.2±3.3 P0.01
sF-social functioning 9.2±3.9 14.2±4.5 P0.01
re-role emotional 14.1±7.3 19.1±8.9 P0.01
Mh-mental health 4.2±4.9 4.7±4.0 P=0.78
Abbreviations: AsD, atrial septal defect; sF-36, short Form (36) health survey.
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Our study results demonstrate that device closure of ASDs 
in the elderly is technically easy, safe, and with minimal com-
plications. We did not encounter any serious complications, 
such as erosion, device migration, thrombus formation, or 
embolic events, during the procedure or at follow-up. In our 
study, supraventricular arrhythmia occurring de novo after 
device implantation was temporal and disappeared in 1 year’s 
time. None of the rhythm disorders recorded in our patients 
had an impact on the postoperative period. No additional 
hospitalizations or other clinical incidences were associated 
with arrhythmias.
The aim of the study was to evaluate the results of 
transcatheter closure of ASDs in elderly patients. All 
those patients had a coexisting impairment of physical 
status, enlargement of the right-heart cavity, or pulmonary 
hypertension. No major complications occurred during 
the hospital stay, which is consistent with the reports in 
the literature.10–13 All patients survived and remained well, 
with no complications or new symptoms at their 12-month 
follow-up. No patient has had any heart-related hospital 
admissions. All the patients completed 12 months of 
follow-up. In our opinion, even elderly patients with clini-
cal impairment and right-heart enlargement could benefit 
from ASD closure.
In our study, closure of the ASD resulted in significant 
improvement of the clinical status of patients in early 
follow-up. It caused a reduction of breathlessness and pal-
pitation. There were no patients who had not improved; the 
improvement was even recognized in the group of patients 
with pulmonary arterial hypertension.
One of the most difficult problems for the treatment of 
ASDs in elderly patients is comorbid disease. More than a 
third of patients have systemic hypertension and other sys-
temic diseases, such as diabetes mellitus or cerebral infarc-
tion. Cardiac comorbidities, such as pulmonary hypertension, 
ventricular dysfunction, atrial arrhythmia, and ischemic 
heart disease, are known to make transcatheter closure more 
complicated.12,13 In our study, ten patients had ischemic heart 
disease. In four cases, we performed percutaneous translu-
minal coronary angioplasty with stent implantation before 
ASD closure, and in six patients we applied pharmacological 
treatment for the ischemic heart disease.
Some reports have documented that substantial reverse 
remodeling of the heart after closure improves symptoms and 
functional status.14–19 However, we found a great reduction in 
right-heart dimensions after device closure. Nearly all patients 
showed improvement: reduction of symptoms, an improve-
ment in functional and exertional capacity, and significant 
hemodynamic improvement. Peak oxygen-consumption 
numbers at baseline in cardiopulmonary exercise tests were 
correct, and respiratory exchange ratio values were  similar 
for all observation times; we hypothesized that before 
ASD  closure, patients did not exercise maximally and feared 
more effort, although they were encouraged to exercise by 
the practitioner in the same way as after ASD closure.
Quality of life improved, as did exercise capacity. The 
objective clinical status of the patients (cardiopulmonary 
exercise tests, echo examination) improved as well as their 
subjective opinions of their quality of life. Therefore, we 
believe that it is really worthwhile to close ASDs in elderly 
patients with coexisting impairment of physical status, 
enlargement of right-heart cavity, or pulmonary hyperten-
sion. Regardless of the patient’s age, clinical improvement 
is possible. Right-heart remodeling and improvement in 
quality of life and physical status can occur in those elderly 
patients. Naturally, each case should be analyzed and quali-
fied individually.
study limitations
The major limitations of the present study were its nonran-
domized nature and the lack of a control group.
Conclusion
Closure of ASDs in elderly patients resulted in significant 
clinical and hemodynamic improvement after percutaneous 
treatment, which requires long-term follow-up. Right-heart 
remodeling can occur in patients 60 years of age.
Disclosure
The authors report no conflicts of interest in this work.
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